Evidence map›Paper›PMID 32859919›Full record

ArticleNature communications2020

Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology.

Huan Chen, David H Vandorpe, Xiang Xie, Seth L Alper, Mark L Zeidel, Weiqun Yu

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. CaClinical and experimental pharmacology & physiology · 2026
    Article
  2. Article
  3. Review
  4. Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction with Abnormal Smooth Muscle Contractility.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ectonucleotidases and purinergic receptors in mouse prostate gland.American journal of clinical and experimental urology · 2025
    Article
  11. Review
  12. Article
  13. Depression of CaJournal of pharmaceutical analysis · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Huan ChenDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
David H VandorpeDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Xiang XieDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Seth L AlperDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6228-2512
Mark L ZeidelDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Weiqun YuDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wyu2@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · US

Funding

Role of Insulin Receptor-mediated Signaling In Underactive BladderR21AG064633 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YU, WEIQUN · 2019 to 2020
$481k
Targeting Cav1.2 to treat Ketamine-Induced PathologyU18DA052346 · NIDA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YU, WEIQUN · 2020 to 2020
$263k
NIA NIH HHS R21 AG064633NIDA NIH HHS U18 DA052346
6 · The paper itself

Abstract

The general anesthetic ketamine has been repurposed by physicians as an anti-depressant and by the public as a recreational drug. However, ketamine use can cause extensive pathological changes, including ketamine cystitis. The mechanisms of ketamine's anti-depressant and adverse effects remain poorly understood. Here we present evidence that ketamine is an effective L-type Ca

Indexed as

AnimalsCalciumCalcium Channels, L-TypeCell ProliferationCystitisDisease Models, AnimalHumansKetamineKidneyMiceMice, KnockoutMuscle, SmoothOocytesReceptors, N-Methyl-D-AspartateSignal TransductionUrinary BladderCalciumCalcium Channels, L-TypeKetamineL-type calcium channel alpha(1C)Receptors, N-Methyl-D-Aspartate

Identifiers

PMID32859919
PMCPMC7455701
OpenAlexW3082280244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.